EUVIMEDEUVIMED entdecken
Open Access

Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment

Parisa Aziminezhadan iD, Mahsa Jafari Harandi iD, Faranak Olamaeian iD, Mohammadjavad Ashoori iD, Ali Tayebi iD

Indian Journal of Surgical Oncology · 2026-01 · 17 (1) · 96-103

DOI: 10.1007/s13193-025-02263-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Surgical Oncology, online erschienen am 22.04.2025. Verfasst von Parisa Aziminezhadan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Aziminezhadan Breast Clinic, Tehran, Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraductal papillomas (IDPs) are benign breast lesions with potential for malignant transformation. This study aimed to determine the upgrade rate of de-novo IDPs to malignancy, identify associated risk factors, and assess the 6-month outcome after treatment. This retrospective cohort study included 320 patients diagnosed with de-novo IDP at a breast surgery clinic in Tehran, Iran, between March 2011 and March 2022. Patients were divided into upgraded (malignant) and non-upgraded (benign) groups based on pathology results from core needle biopsy (CNB) or vacuum-assisted excision (VAE). Baseline characteristics, pathology outcomes, and follow-up outcomes were analyzed. Multivariable logistic regression identified risk factors for malignant upgrade. Of the 320 participants, 16 (5.0%) had upgraded (malignant) IDPs, and 304 (95.0%) had non-upgraded (benign) IDPs. The median age was significantly higher in the upgraded group (53 years) compared to the non-upgraded group (43 years) (p < 0.001). Age ≥ 50 years was a significant risk factor for malignant upgrade (, p < 0.001). The most common malignant pathology was ductal carcinoma in situ (DCIS) (68.8%). Age was identified as a significant risk factor for malignancy, with older age increasing the likelihood of an upgrade (OR = 1.249, p = 0.02). After 6 months follow-up, three patients with IDP were detected by sonography. Older age was the sole significant risk factor for malignant transformation of IDPs. Continuous follow-up is recommended, especially for older patients, to promptly detect potential recurrence or malignant progression.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerIntraductal papillomaMalignant transformationRisk factors

Autor:innen und Institutionen

  • Aziminezhadan Breast Clinic, Tehran, Iran.
  • Deparment of General Surgery, School of Medicine, Tehran, Iran.
  • Firoozabadi Clinical Research Development Unit (F A CRD U, School of Medicine, Tehran, Iran.
  • International Campus, Tehran, Iran.
  • Firoozabadi Clinical Research Development Unit ( F A CRD U, School of Medicine, Tehran, Iran.

ORCID-Profile: Parisa Aziminezhadan, Mahsa Jafari Harandi, Faranak Olamaeian, Mohammadjavad Ashoori, Ali Tayebi

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Aziminezhadan, P., Harandi, M. J., Olamaeian, F., Ashoori, M., & Tayebi, A. (2026). Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment. Indian Journal of Surgical Oncology, 17(1), 96-103. https://doi.org/10.1007/s13193-025-02263-2

Vancouver

Aziminezhadan P, Harandi MJ, Olamaeian F, Ashoori M, Tayebi A. Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment. Indian Journal of Surgical Oncology. 2026;17(1):96-103. doi:10.1007/s13193-025-02263-2

BibTeX
@article{Aziminezhadan2026,
  author = {Aziminezhadan, Parisa and Harandi, Mahsa Jafari and Olamaeian, Faranak and Ashoori, Mohammadjavad and Tayebi, Ali},
  title = {Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment},
  journal = {Indian Journal of Surgical Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {96--103},
  doi = {10.1007/s13193-025-02263-2}
}
Kostenlos starten →